Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Minoxidil and finasteride effectively treat hair loss but may cause side effects; combining them improves results.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

Stopping finasteride improved seizure control, suggesting neurosteroids affect seizures and treatment.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.

Ruxolitinib cream may help treat severe hair loss in children.

Combination drug therapy improves hair growth and patient care for androgenetic alopecia.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Ecklonia cava improves the effectiveness of Diane-35 in managing PCOS symptoms.

The FDA did not approve a testosterone drug because of safety concerns.

Topical estrogens improved hair growth in about half of the patients.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Etretinate treatment changed hair growth patterns in many patients.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

New treatments for common hair loss are needed.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Adding yeast extract and methyl jasmonate to Eclipta alba cell cultures increased the production of the compound wedelolactone.